Table of Contents Table of Contents
Previous Page  86 / 1119 Next Page
Information
Show Menu
Previous Page 86 / 1119 Next Page
Page Background

3

rd

most common gynecologic malignancy

Clinical staging can under- or over-stage disease

Accurate Tumor size not determined

Nodal status not determined

Parametrial assessment,Pelvic side wall ?

Concordance between surgical and clinical FIGO staging poor

(85.4, 77.4, 35.3, and 20.5% for stage IB, IB2, IIA, and IIB)

Qin Y et al. Aust N Z J Obstet Gynaecol 49.5 (2009): 542-544

18

CERVICAL CANCER